Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ARSENIC TRIOXIDE Cause Product use issue? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product use issue have been filed in association with ARSENIC TRIOXIDE (Vermasode). This represents 0.5% of all adverse event reports for ARSENIC TRIOXIDE.

6
Reports of Product use issue with ARSENIC TRIOXIDE
0.5%
of all ARSENIC TRIOXIDE reports
0
Deaths
1
Hospitalizations

How Dangerous Is Product use issue From ARSENIC TRIOXIDE?

Of the 6 reports, 1 (16.7%) required hospitalization.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ARSENIC TRIOXIDE. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does ARSENIC TRIOXIDE Cause?

Differentiation syndrome (180) Electrocardiogram qt prolonged (148) Off label use (128) Acute promyelocytic leukaemia differentiation syndrome (51) Hyperleukocytosis (49) Drug ineffective (45) Acute kidney injury (42) Leukaemia recurrent (41) Hypokalaemia (40) Idiopathic intracranial hypertension (38)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which ARSENIC TRIOXIDE Alternatives Have Lower Product use issue Risk?

ARSENIC TRIOXIDE vs ARTEMETHER\LUMEFANTRINE ARSENIC TRIOXIDE vs ARTESUNATE ARSENIC TRIOXIDE vs ARTICAINE\EPINEPHRINE ARSENIC TRIOXIDE vs ASCIMINIB ARSENIC TRIOXIDE vs ASCORBIC ACID

Related Pages

ARSENIC TRIOXIDE Full Profile All Product use issue Reports All Drugs Causing Product use issue ARSENIC TRIOXIDE Demographics